A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP.

Zhou, Hai

A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP. [electronic resource] - Blood Mar 2015 - 1541-7 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1528-0020

10.1182/blood-2014-06-581868 doi


Adolescent
Adrenal Cortex Hormones--therapeutic use
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Autoantibodies--blood
Child
Combined Modality Therapy
Drug Resistance
Female
Humans
Male
Middle Aged
Platelet Count
Purpura, Thrombocytopenic, Idiopathic--blood
Recombinant Proteins--administration & dosage
Recurrence
Rituximab
Thrombopoietin--administration & dosage
Treatment Outcome
Young Adult